| PERIOD ENDING | 28-Feb-09 | 29-Feb-08 | 28-Feb-07 | | Total Revenue | 28,621 | 98,539 | 101,535 | | Cost of Revenue | 27,071 | 85,135 | 84,065 | | | Gross Profit | 1,550 | 13,404 | 17,470 | | | Operating Expenses | | Research Development | 1,564 | 1,887 | 1,840 | | Selling General and Administrative | 14,046 | 24,866 | 33,121 | | Non Recurring | (3,330) | 1,958 |
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (10,730) | (15,307) | (17,491) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
| | Earnings Before Interest And Taxes | (10,730) | (15,307) | (17,491) | | Interest Expense | 207 | 1,300 | 803 | | Income Before Tax | (10,937) | (16,607) | (18,294) | | Income Tax Expense | (2,025) | 1,114 | 888 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (8,912) | (17,721) | (19,182) | | | Non-recurring Events | | Discontinued Operations | 1,799 |
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (7,113) | (17,721) | (19,182) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($7,113) | ($17,721) | ($19,182) |
|
0.12% Nasdaq 
0.18%
Income Statement
